Streptococcus milleri group

(redirected from Streptococcus anginosus group)

Strep·to·coc·cus mil·ler·i group

(strep'tō-kok'ŭs mil'ler-ī grūp)
A term used to refer to the Streptococcus intermedius group, which contains three distinct streptococcal species: S. intermedius, S. constellatus, and S. anginosus. These bacteria are found in the human oral cavity and have been associated with a variety of infections including bacteremia, endocarditis, and central nervous system, oral, and thoracic infections.
References in periodicals archive ?
The Streptococcus anginosus group is made up of three species, S.
Culture-negative intracerebral abscesses in children and adolescents from Streptococcus anginosus group infection: a case series," Clinical Infectious Diseases, vol.
DALVANCE[R]) for the treatment of ABSSI caused by Gram-positive microorganisms such as methicillin-susceptible Staphylococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pyogenes, Streptococcus agalactiae, and Streptococcus anginosus group.
Genotyping by amplified fragment length polymorphism analysis reveals persistence and recurrence of infection with Streptococcus anginosus group organisms.
VIBATIV (telavancin) is approved in the US and in Canada for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible isolates of the following Gram-positive microorganisms: Staphylococcus aureus (including methicillin-susceptible and -resistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus anginosus group (includes S.
The proposed indication for telavancin is for the treatment of complicated skin and skin structure infections (cSSSI) caused by Staphylococcus aureus (including methicillin-resistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, the Streptococcus anginosus group, and Enterococcus faecalis.